Skip to content

PROCEPT BioRobotics Corporation PRCT Change in Deferred Revenue

Change in Deferred Revenue at other companies

Absci Corporation logo
Absci CorporationABSI
-$83K-315%
iRadimed logo
iRadimedIRMD
$305K-44.2%
ROP
Roper Technologies, Inc.ROP
-$117.1M-65.9%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$35M+151%
Teradyne, Inc. logo
Teradyne, Inc.TER
$51.96M+409%

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.19B-24.8%
Enterprise value$1.25B
P/S3.7×

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's change in deferred revenue?
PROCEPT BioRobotics Corporation (PRCT) reported change in deferred revenue of $628K in Q1 2026.
How has PROCEPT BioRobotics Corporation's change in deferred revenue changed year-over-year?
PROCEPT BioRobotics Corporation's change in deferred revenue increased by 167.2% year-over-year, from $235K to $628K.
What is the long-term trend for PROCEPT BioRobotics Corporation's change in deferred revenue?
Over 4 years (2021 to 2025), PROCEPT BioRobotics Corporation's change in deferred revenue has grown at a 43.1% compound annual growth rate (CAGR), from $792K to $3.32M.
What does change in deferred revenue mean?
Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.